首页 | 本学科首页   官方微博 | 高级检索  
     

复方苁蓉益智胶囊联合奥拉西坦治疗轻中度血管性痴呆的临床研究
引用本文:徐美杰,阎涛,赵理乐,康军,南景一. 复方苁蓉益智胶囊联合奥拉西坦治疗轻中度血管性痴呆的临床研究[J]. 现代药物与临床, 2021, 36(8): 1594-1598
作者姓名:徐美杰  阎涛  赵理乐  康军  南景一
作者单位:天津市西青医院 神经内科,天津 300380;天津医科大学总医院 神经内科,天津 300052;菏泽步长制药有限公司,山东 菏泽 274000
基金项目:南通市科技局项目(JCZ20170);南通市青年课题A项目(QA2019022);南通市青年课题(QA2019024)
摘    要:目的 探讨复方苁蓉益智胶囊联合奥拉西坦注射液治疗轻中度血管性痴呆的临床效果.方法 选取2018年1月—2020年1月天津市西青医院收治的120例血管性痴呆患者,奇偶顺序法分为对照组和治疗组,每组各60例.对照组静脉滴注奥拉西坦注射液,4 g加入到500 mL生理盐水,1次/d.治疗组在对照组的基础上口服复方苁蓉益智胶囊...

关 键 词:复方苁蓉益智胶囊  奥拉西坦注射液  血管性痴呆  日常生活能力量表  同型半胱氨酸  脑源性神经营养因子
收稿时间:2021-03-01

Clinical study on Compound Congrong Yizhi Capsules combined with oxiracetam in treatment of mild to moderate vascular dementia
XU Mei-jie,YAN Tao,ZHAO Li-le,KANG Jun,NAN Jing-yi. Clinical study on Compound Congrong Yizhi Capsules combined with oxiracetam in treatment of mild to moderate vascular dementia[J]. Drugs & Clinic, 2021, 36(8): 1594-1598
Authors:XU Mei-jie  YAN Tao  ZHAO Li-le  KANG Jun  NAN Jing-yi
Affiliation:Nantong Hospital of Traditional Chinese Medicine, Nantong Hospital Affiliated to Nanjing University of Chinese Medicine, Nantong 226000, China;Nantong Hospital of Traditional Chinese Medicine, Nantong Hospital Affiliated to Nanjing University of Chinese Medicine, Nantong 226000, China;Nanjing University of Chinese Medicine, Jiangsu Provincial Key Laboratory of Chinese Medicine Processing, Engineering Center of State Ministry of Education for Standardization of Chinese Medicine Processing, Nanjing 210023, China
Abstract:Objective To investigate the clinical effect of Compound Congrong Yizhi Capsules combined with oxiracetam in treatment of mild to moderate vascular dementia. Methods Patients (120 cases) with mild to moderate vascular dementia in Tianjin Xiqing Hospital from January 2018 to January 2020 were divided into control and treatment groups based on parity order, and each group had 30 cases. Patients in the control group were iv administered with Oxiracetam Injection, 4 g added into normal saline 500 mL, once daily. Patients in the treatment group were po administered with Compound Congrong Yizhi Capsules, 4 grains/time, three times daily. Patients in two groups were treated for 4 weeks. After treatment, the clinical efficacy was evaluated, the MMSE, ADL, and NIHSS scores, and the levels of serum BDNF, Hcy, and IGF-1 in two groups before and after treatment were compared. Results After treatment, the clinical effective rate in the treatment group was higher than that in the control group (91.67% vs 76.67%, P < 0.05). After treatment, the MMSE score in two groups were significantly increased, while the scores of ADL and NIHSS were significantly decreased (P < 0.05), and the scores of the treatment group were significantly better than that of the control group (P < 0.05). After treatment, BDNF and IGF-1 in two groups were significantly increased, while Hcy were significantly decreased (P < 0.05), and which in the treatment group were significantly better than those in the control group (P < 0.05). Conclusion Compound Congrong Yizhi Capsules combined with oxiracetam is safe and effective on treatment of mild to moderate vascular dementia, can improve patients'' cognitive function, self-care ability, and promote the improvement of symptoms.
Keywords:Glutathione Tablets  alcoholic fatty liver disease  zebrafish  inflammatory factors
本文献已被 万方数据 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号